PuSH - Publication Server of Helmholtz Zentrum München

Kyrkou, S.G.* ; Vrettos, E.I.* ; Gorpas, D. ; Crook, T.* ; Syed, N.* ; Tzakos, A.G.*

Design principles governing the development of theranostic anticancer agents and their nanoformulations with photoacoustic properties.

Pharmaceutics 14:362 (2022)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The unmet need to develop novel approaches for cancer diagnosis and treatment has led to the evolution of theranostic agents, which usually include, in addition to the anticancer drug, an imaging agent based mostly on fluorescent agents. Over the past few years, a non-invasive pho-toacoustic imaging modality has been effectively integrated into theranostic agents. Herein, we shed light on the design principles governing the development of theranostic agents with photoa-coustic properties, which can be formulated into nanocarriers to enhance their potency. Specifi-cally, we provide an extensive analysis of their individual constituents including the imaging dyes, drugs, linkers, targeting moieties, and their formulation into nanocarriers. Along these lines, we present numerous relevant paradigms. Finally, we discuss the clinical relevance of the specific strategy, as also the limitations and future perspectives, and through this review, we envisage paving the way for the development of theranostic agents endowed with photoacoustic properties as effective anticancer medicines.
Impact Factor
Scopus SNIP
Altmetric
6.525
1.364
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Review
Keywords Cancer ; Nanoformulations ; Photoacoustic ; Phototherapy ; Theranostics
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 1999-4923
e-ISSN 1999-4923
Journal Pharmaceutics
Quellenangaben Volume: 14, Issue: 2, Pages: , Article Number: 362 Supplement: ,
Publisher MDPI
Reviewing status Peer reviewed
POF-Topic(s) 30205 - Bioengineering and Digital Health
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-505500-001
Scopus ID 85124335659
PubMed ID 35214094
Erfassungsdatum 2022-06-24